Advertisement

Bulletin of Experimental Biology and Medicine

, Volume 89, Issue 3, pp 315–318 | Cite as

Immunologic specificity, nature, and properties of suppressor cells induced in mixed lymphocyte cultures

  • B. D. Brondz
  • A. V. Karaulov
Microbiology and Immunology
  • 20 Downloads

Abstract

After incubation of lymphocytes 1–5 days in allogeneic or syngeneic one-way mixed lymphocyte culture (MLC) suppressor cells blocking proliferation of 10 to 100 times as many syngeneic responding lymphocytes in fresh allogeneic MLC are generated. Neither “allogeneic” nor “syngeneic” suppressors have the properties either of B-cells or macrophages, both are resistant to mitomycin C, but their precursors are sensitive to cyclophosphamide. They differ in their properties both from T-killers and from T-suppressors induced in a lymphocyte monoculture. The “allogeneic” suppressors are heterogeneous T-cells as regards radiosensitivity and specificity. The formation of nonspecific T-suppressors is considerably reduced if embryonic calf serum in the medium is replaced by human or bovine serum. “Syngeneic” suppressors also are heterogeneous and differ from “allogeneic” in their greater resistance to anti-T-antibodies and irradiation, whereas their precursors are more resistant to hydrocortisone.

Key Words

suppressors mixed lymphocyte culture activation of DNA synthesis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature Cited

  1. 1.
    B. D. Brondz, E. Ya. Khachikyan, G. I. Drizlikh, et al., Byull. Éksp. Biol. Med., No. 6, 723 (1977).Google Scholar
  2. 2.
    A. V. Karaulov, N. F. Abronina, and B. D. Brondz, Byull. Éksp. Biol. Med., No. 10, 429 (1970).Google Scholar
  3. 3.
    A. R. Al-Adra and L. M. Pilarski, Eur. J. Immunol.,8, 504 (1978).PubMedGoogle Scholar
  4. 4.
    L. M. Ching, J. Marbrook, and K. Z. Walker, Cell Immunol.,31, 284 (1977).PubMedGoogle Scholar
  5. 5.
    A. Eisenthal, D. Nachtigal, and M. Feldman, Cell Immunol.,34, 112 (1977).PubMedGoogle Scholar
  6. 6.
    F. W. Fitch, H. D. Engers, J. C. Cerottini, et al., J. Immunol.,116, 716 (1976).PubMedGoogle Scholar
  7. 7.
    J. L. Glick, C. Lockwood, J. Williams, et al., Transplantation,18, 86 (1974).PubMedGoogle Scholar
  8. 8.
    K. S. Hathcock, W. D. Terry, and R. Hodes, Fed. Proc.,37, 1492 (1978).Google Scholar
  9. 9.
    T. Hirano and A. A. Nordin, J. Immunol.,116, 1115 (1976).PubMedGoogle Scholar
  10. 10.
    R. J. Hodes, L. M. Nadler, and R. S. Hathcock, J. Immunol.,119, 961 (1977).PubMedGoogle Scholar
  11. 11.
    C. A. Janeway, S. O. Sharrow, and E. Simpson, Nature,253, 544 (1975).PubMedGoogle Scholar
  12. 12.
    E. Kedar, M. Schwartzback, E. Unger, et al., Transplantation,26, 63 (1978).PubMedGoogle Scholar
  13. 13.
    M. Nabholz, J. Viver, H. M. Young, et al., Eur. J. Immunol.,4, 378 (1974).PubMedGoogle Scholar
  14. 14.
    A. V. Peck, R. A. Murgita, and H. W. Wigzell, J. Exp. Med.,148, 360 (1978).PubMedGoogle Scholar
  15. 15.
    P. M. Sondel, M. W. Jacobson, and F. M. Bach, Eur. J. Immunol.,7, 38 (1977).PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1980

Authors and Affiliations

  • B. D. Brondz
  • A. V. Karaulov

There are no affiliations available

Personalised recommendations